Clinical Trials Directory

Trials / Completed

CompletedNCT04545970

A Clinical Study to Evaluate Efficacy and Safety of a Cosmetic Product in the Treatment of Facial Lines

A Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of an Anti-Aging Serum in the Treatment of Facial Lines

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
56 (actual)
Sponsor
Revision Skincare · Industry
Sex
Female
Age
35 Years – 60 Years
Healthy volunteers
Accepted

Summary

This randomized, double-blind, placebo-controlled clinical trial was conducted to assess the efficacy and safety of an anti-aging serum to improve the appearance of expression lines as well as overall skin health of aging skin after 12 weeks of twice-daily use in female subjects, aged 35-60, compared to placebo. A total of 55 subjects completed study participation which included 33 subjects in the active group and 22 subjects in the placebo group.

Detailed description

This randomized, double-blind, placebo-controlled clinical trial is being conducted to assess the efficacy and safety of the anti-aging serum when used over the course of 12 weeks by women with mild to moderate fine lines, wrinkles and overall photodamage on the global face. Efficacy and tolerability will be assess through clinical grading at baseline, weeks 4, 8, and 12. Efficacy evaluation on fine lines and wrinkles through clinical grading will also be performed at 15 minutes post product application. Self-assessment questionnaires and VISIA photography will be completed at baseline, weeks 4, 8, and 12. 3D PRIMOS photography will be performed at baseline, weeks 8 and 12. A total of 55 subjects completed study participation which included 33 subjects in the active group and 22 subjects in the placebo group.

Conditions

Interventions

TypeNameDescription
COMBINATION_PRODUCTFacial cleanserFacial cleanser to be used by study participants
COMBINATION_PRODUCTFacial moisturizerBland moisturizer to be used by study participants after serum in the evening.
COMBINATION_PRODUCTSunscreenSunscreen to be applied after application of serum in the morning.

Timeline

Start date
2019-12-23
Primary completion
2020-03-11
Completion
2020-07-06
First posted
2020-09-11
Last updated
2020-09-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04545970. Inclusion in this directory is not an endorsement.